17-alpha-Hydroxyprogesterone
"17-alpha-Hydroxyprogesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.
| Descriptor ID |
D019326
|
| MeSH Number(s) |
D04.210.500.745.745.654.829.395.400 D06.472.334.851.687.750.478.400
|
| Concept/Terms |
17-alpha-Hydroxyprogesterone- 17-alpha-Hydroxyprogesterone
- 17 alpha Hydroxyprogesterone
- 17-Hydroxyprogesterone, (17 alpha)-Isomer
- 17-Hydroxyprogesterone
- 17 Hydroxyprogesterone
- 17 alpha-Hydroxyprogesterone
|
Below are MeSH descriptors whose meaning is more general than "17-alpha-Hydroxyprogesterone".
Below are MeSH descriptors whose meaning is more specific than "17-alpha-Hydroxyprogesterone".
This graph shows the total number of publications written about "17-alpha-Hydroxyprogesterone" by people in this website by year, and whether "17-alpha-Hydroxyprogesterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "17-alpha-Hydroxyprogesterone" by people in Profiles.
-
Placental histology for targeted risk assessment of recurrent spontaneous preterm birth. Am J Obstet Gynecol. 2024 04; 230(4):452.e1-452.e11.
-
Evaluation and Treatment of Hirsutism in Premenopausal Women. JAMA. 2018 Apr 17; 319(15):1613-1614.
-
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol. 2015 Dec; 28(6):412-9.
-
Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod. 2011 Nov; 26(11):3138-46.
-
Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
-
Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006 Oct; 91(10):3786-90.
-
Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2002 Jun; 87(6):2993; author reply 2993.
-
The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
-
Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency. N Engl J Med. 2000 Oct 19; 343(16):1197-8.
-
A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod. 1997 Jul; 12(7):1416-20.